Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07225829 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

Study acronym: INFLAM MOTION
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Aug 28, 2026 to Aug 31, 2026
    • Study completion date: Sep 2026 to Oct 28, 2026
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 11 of 15 entries
  2. Enrollment closed, study ongoing
    • Primary completion pushed from Jul 2026 to Aug 28, 2026
    • Site details revised at 22 of 22 sites
    v3
  3. Study sites: 21 to 22
    • Primary completion date: May 2026 to Jul 2026
    • Study completion date: May 2026 to Sep 2026
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase 2a trial is an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of one single intra-articular (IA) injection of 4P004 or placebo in: * patients between 40 and 80 years of age, * with synovitis and grade 2 to 4 osteoarthritis (OA) of the knee according to Kellgren and Lawrence (KL) classification.
Trial Details
NCT Number NCT07225829
Lead Sponsor 4Moving Biotech
Conditions
(from sponsor)		 Knee Osteoarthritis, Synovitis of Knee
Related terms Osteoarthritis, Osteoarthritis, Knee
Enrollment 129 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov